Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically proven squamous cell carcinoma of oral cavity. 2. ECOG PS: 0 – 2. 3. Resectable stage I – IV tumours.
Exclusion criteria
Exclusion criteria: 1. Patients with recurrent or residual head and neck cancers or second primaries treated with radiation with or without chemotherapy 2. Presence of synchronous malignancies. 3. Previous history of radiotherapy and/or chemotherapy for any other malignancy. 4. Patients with severe medical illness that preclude full participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A subset of differentially expressed tumor immune infiltarates in tumor-core and tumor-stroma predict 1-year locoregional recurrence and distant metastasis.Timepoint: At the time of surgery, 3 months, 6 months, 9 months and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| A validated IHC panel to be used as a prognostic biomarker in oral squamous cell carcinoma.Timepoint: IEC approval, training of manpower: April 2020 - June 2020. Accrual: July 2020 - February 2021. Follow up, data analysis: March 2021 - February 2022. | — |
Countries
India
Contacts
All India Institute of Medical Sciences Rishikesh